Pfēnex Expression Technology™

Pfēnex Expression Technology™ is a robust Pseudomonas fluorescens-based platform with high throughput methodology for optimized strain identification for protein production. It is an extraordinarily flexible platform, being used to produce innovative therapeutics and vaccines, research-tool proteins, prospective lead therapeutics and vaccine antigens, as well as biosimilars in a variety of therapeutic areas. Pfēnex Expression Technology has also been used successfully as a high throughput screen for discovery based applications, particularly in early stage hit-to-lead applications and novel antigen and antibody identification. Hence, the technology provides a system by which proteins can be produced with the highest quality and speed, facilitating product development and maximizing the pipeline with proteins in development, and ultimately into the marketplace. The Pfēnex Expression Technology’s unprecedented success rate in the expression of high titers of soluble, active protein makes a compelling case for selecting Pfēnex first for the expression of all protein types.